Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04330339 · ClinicalTrials.gov registry record · NA
Prolonged Nightly Fasting in Breast Cancer Survivors
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04330339: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04330339 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04330339, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is being done to examine whether fasting for 13 hours every night is feasible and if it can help breast cancer survivors lose weight and improve their health. * Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring. Recent research suggests that prolonged nighttime fasting (\>13 hours) may improve the risk of recurrence for breast cancer. * This study will examine if fasting for 13 hours per night is doable for participants and will also study what the effect of fasting is on quality of life, mood, fatigue, body size, and markers of health in the blood.
Interventions
- BEHAVIORAL Fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-07-24 |
| Est. Completion | 2022-07-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04330339
The ClinicalTrials.gov registry entry for NCT04330339 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fasting is the first listed.
NCT04330339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04330339 about?
NCT04330339 is a clinical study titled "Prolonged Nightly Fasting in Breast Cancer Survivors". This study is being done to examine whether fasting for 13 hours every night is feasible and if it can help breast cancer survivors lose weight and improve their health. * Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater...
What is the current status of trial NCT04330339?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-07-24. Estimated completion is 2022-07-05.
What interventions are being tested in trial NCT04330339?
The interventions under investigation include: Fasting (BEHAVIORAL).
Who is sponsoring clinical trial NCT04330339?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.